Paper22345482
Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cells.
Salamon D and 8 others. J Virol, 2012. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cells. Papers, record 22345482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22345482
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cells.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| B-Lymphocytes | Major topic |
| Herpesvirus 4, Human | Major topic |
| Interferon Type I | Major topic |
| Viral Matrix Proteins | Major topic |
| Cell Line | |
| Gene Expression Regulation, Viral | |
| Humans | |
| Molecular Sequence Data | |
| Promoter Regions, Genetic | |
| Signal Transduction | |
| Transcription, Genetic | |
| Virus Latency |
Source PubMed
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1832772 | Transmembrane signaling by interferon alpha involves diacylglycerol production and activation of the epsilon isoform of protein kinase C in Daudi cells. | Proc Natl Acad Sci U S A | 1991 | https://conductscience.org/library/papers/1832772 | PubMed |
| 2 | 6161964 | The transformation of adult but not newborn human lymphocytes by Epstein Barr virus and phytohemagglutinin is inhibited by interferon: the early suppression by T cells of Epstein Barr infection is mediated by interferon. | J Immunol | 1981 | https://conductscience.org/library/papers/6161964 | PubMed |
| 3 | 22204827 | Type I interferons directly down-regulate BCL-6 in primary and transformed germinal center B cells: differential regulation in B cell lines derived from endemic or sporadic Burkitt's lymphoma. | Cytokine | 2012 | https://conductscience.org/library/papers/22204827 | PubMed |
| 4 | 2470924 | 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael. | J Virol | 1989 | https://conductscience.org/library/papers/2470924 | PubMed |
| 5 | 6291233 | Inhibition of Epstein-Barr virus-associated nuclear antigen (EBNA) induction by (2',5')oligoadenylate and the cordycepin analog: mechanism of action for inhibition of EBV-induced transformation. | Virology | 1982 | https://conductscience.org/library/papers/6291233 | PubMed |
| 6 | 2479717 | The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus. | J Gen Virol | 1989 | https://conductscience.org/library/papers/2479717 | PubMed |
| 7 | 11405234 | Epigenetics of latent Epstein-Barr virus genomes: high resolution methylation analysis of the bidirectional promoter region of latent membrane protein 1 and 2B genes. | Biol Chem | 2001 | https://conductscience.org/library/papers/11405234 | PubMed |
| 8 | 19720839 | Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. | J Exp Med | 2009 | https://conductscience.org/library/papers/19720839 | PubMed |
| 9 | 7769727 | The Epstein-Barr virus 3.5-kilobase latent membrane protein 1 mRNA initiates from a TATA-Less promoter within the first terminal repeat. | J Virol | 1995 | https://conductscience.org/library/papers/7769727 | PubMed |
| 10 | 8386282 | Inhibition of Epstein-Barr virus-mediated capping of CD21/CR2 by alpha interferon (IFN-alpha): immediate antiviral activity of IFN-alpha during the early phase of infection. | J Virol | 1993 | https://conductscience.org/library/papers/8386282 | PubMed |
| 11 | 12219084 | Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. | Nat Med | 2002 | https://conductscience.org/library/papers/12219084 | PubMed |
| 12 | 20876453 | STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma. | Blood | 2011 | https://conductscience.org/library/papers/20876453 | PubMed |
| 13 | 16332968 | IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines. | Blood | 2006 | https://conductscience.org/library/papers/16332968 | PubMed |
| 14 | 1371012 | Host-cell-phenotype-dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens 2-6. | Proc Natl Acad Sci U S A | 1992 | https://conductscience.org/library/papers/1371012 | PubMed |
| 15 | 2848918 | B cell activation and the establishment of Epstein-Barr virus latency. | J Exp Med | 1988 | https://conductscience.org/library/papers/2848918 | PubMed |
| 16 | 10777558 | Distinct mechanisms of STAT phosphorylation via the interferon-alpha/beta receptor. Selective inhibition of STAT3 and STAT5 by piceatannol. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10777558 | PubMed |
| 17 | 2580994 | Effects of pure interferons on Epstein-Barr virus infection in vitro. | J Virol | 1985 | https://conductscience.org/library/papers/2580994 | PubMed |
| 18 | 8178450 | Sequence-specific methylation inhibits the activity of the Epstein-Barr virus LMP 1 and BCR2 enhancer-promoter regions. | Virology | 1994 | https://conductscience.org/library/papers/8178450 | PubMed |
| 19 | 2439466 | Anti-proliferative effects of interferons on Daudi Burkitt lymphoma cells: induction of cell differentiation and loss of response to autocrine growth factors. | Int J Cancer | 1987 | https://conductscience.org/library/papers/2439466 | PubMed |
| 20 | 20080768 | IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20080768 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33613527 | Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity. | Front Immunol | 2020 | https://conductscience.org/library/papers/33613527 | PubMed |
| 33329556 | Multiple Sclerosis-Like Symptoms in Mice Are Driven by Latent γHerpesvirus-68 Infected B Cells. | Front Immunol | 2020 | https://conductscience.org/library/papers/33329556 | PubMed |
| 32463796 | Cigarette smoke-induced lung inflammation in COPD mediated via CCR1/JAK/STAT /NF-κB pathway. | Aging (Albany NY) | 2020 | https://conductscience.org/library/papers/32463796 | PubMed |
| 28663145 | Type 1 Diabetes and Type 1 Interferonopathies: Localization of a Type 1 Common Thread of Virus Infection in the Pancreas. | EBioMedicine | 2017 | https://conductscience.org/library/papers/28663145 | PubMed |
| 26819314 | Induction of Epstein-Barr Virus Oncoprotein LMP1 by Transcription Factors AP-2 and Early B Cell Factor. | J Virol | 2016 | https://conductscience.org/library/papers/26819314 | PubMed |
| 26579121 | The Role of Latently Infected B Cells in CNS Autoimmunity. | Front Immunol | 2015 | https://conductscience.org/library/papers/26579121 | PubMed |
| 26530011 | EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis. | Leukemia | 2016 | https://conductscience.org/library/papers/26530011 | PubMed |
| 26424647 | EBV Persistence--Introducing the Virus. | Curr Top Microbiol Immunol | 2015 | https://conductscience.org/library/papers/26424647 | PubMed |
| 23760364 | Characterization of human Fab antibody fragments specific to LMP1 (HLEAFab) in nasopharyngeal carcinoma for potential molecular diagnosis and therapeutic applications. | Oncol Lett | 2013 | https://conductscience.org/library/papers/23760364 | PubMed |
| 23342374 | Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation. | Viruses | 2012 | https://conductscience.org/library/papers/23342374 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNA1 | 3439 | PubTator's text mining | https://conductscience.org/library/genes/3439 | NCBI Gene |
| PDLIM7 | 9260 | PubTator's text mining | https://conductscience.org/library/genes/9260 | NCBI Gene |
Data2
The data bank entries PubMed's record names. Trial numbers are under Trials.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22345482
GET https://conductscience.org/api/papers/v1/22345482/references?page=2